financetom
Business
financetom
/
Business
/
Mastercard Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mastercard Unusual Options Activity
Jul 28, 2025 9:24 AM

Financial giants have made a conspicuous bearish move on Mastercard ( MA ). Our analysis of options history for Mastercard ( MA ) revealed 12 unusual trades.

Delving into the details, we found 25% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $748,046, and 4 were calls, valued at $277,942.

What's The Price Target?

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $360.0 to $620.0 for Mastercard ( MA ) over the recent three months.

Volume & Open Interest Development

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Mastercard's ( MA ) options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Mastercard's ( MA ) significant trades, within a strike price range of $360.0 to $620.0, over the past month.

Mastercard 30-Day Option Volume & Interest Snapshot

Noteworthy Options Activity:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
MA PUT TRADE NEUTRAL 08/01/25 $10.0 $9.45 $9.71 $570.00 $323.3K 46 333
MA PUT TRADE NEUTRAL 08/01/25 $7.7 $7.2 $7.46 $565.00 $248.4K 49 0
MA CALL SWEEP BEARISH 01/15/27 $62.85 $61.75 $61.75 $600.00 $148.2K 130 24
MA CALL TRADE BEARISH 03/20/26 $223.85 $222.2 $222.2 $360.00 $66.6K 0 3
MA PUT SWEEP BEARISH 08/15/25 $11.55 $11.4 $11.55 $570.00 $34.6K 326 30

About Mastercard

Mastercard ( MA ) is the second-largest payment processor in the world, having processed close to $10 trillion in volume during 2024. Mastercard ( MA ) operates in over 200 countries and processes transactions in over 150 currencies.

In light of the recent options history for Mastercard ( MA ), it's now appropriate to focus on the company itself. We aim to explore its current performance.

Current Position of Mastercard

Currently trading with a volume of 606,954, the MA's price is down by -0.11%, now at $567.59.

RSI readings suggest the stock is currently may be approaching overbought.

Anticipated earnings release is in 3 days.

What The Experts Say On Mastercard

A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $632.0.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $650.

* Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Mastercard ( MA ), targeting a price of $612.

* In a positive move, an analyst from Seaport Global has upgraded their rating to Buy and adjusted the price target to $616.

* In a cautious move, an analyst from Deutsche Bank downgraded its rating to Buy, setting a price target of $650.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Mastercard ( MA ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
OR Royalties Reports Project Advances at Cascabel, Cariboo and Marimaca, Expects Further 2025 Portfolio Growth
OR Royalties Reports Project Advances at Cascabel, Cariboo and Marimaca, Expects Further 2025 Portfolio Growth
Sep 11, 2025
08:39 AM EDT, 09/11/2025 (MT Newswires) -- OR Royalties ( OR ) reported Thursday positive updates on some of its assets. SolGold continues to advance the Cascabel project in Ecuador, with first production scheduled as early as 2028. A project execution plan has been delivered while work continues on an environmental impact assessment, OR said. OR's interest in Cascabel include...
Foraco to Repurchase Up to 1 Million Shares Under New Normal Course Issuer Bid
Foraco to Repurchase Up to 1 Million Shares Under New Normal Course Issuer Bid
Sep 11, 2025
08:41 AM EDT, 09/11/2025 (MT Newswires) -- Foraco International ( FRACF ) Thursday said the Toronto Stock Exchange has accepted its notice to repurchase up to 1 million shares under a normal course issuer bid. The bid will start Sept. 15 and run for one year. Foraco ( FRACF ) repurchased 956,100 shares under its previous NCIB at a weighted...
GameSquare Acquires Click Management
GameSquare Acquires Click Management
Sep 11, 2025
08:39 AM EDT, 09/11/2025 (MT Newswires) -- GameSquare ( GAME ) said Thursday that it has acquired Click Management for $8.5 million, with the purchase price potentially increasing to $11.5 million upon meeting certain targets. The company said it expects Click to contribute $14.5 million of annualized pro-forma revenue to its topline in H2 2025. The company now expects pro...
Kazia Says Paxalisib Disrupts Tumor Cell Clusters in HER2-Positive Breast Cancer Study
Kazia Says Paxalisib Disrupts Tumor Cell Clusters in HER2-Positive Breast Cancer Study
Sep 11, 2025
08:42 AM EDT, 09/11/2025 (MT Newswires) -- Kazia Therapeutics ( KZIA ) said Thursday that paxalisib monotherapy completely disrupted large circulating tumor cell clusters in blood samples from stage IV HER2-positive breast cancer patients in an ex vivo study conducted by QIMR Berghofer. The company said the treatment also showed statistically significant reduction in single circulating tumor cells, which are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved